Please ensure Javascript is enabled for purposes of website accessibility

Delta, CVS Partner to Accelerate Airline Coronavirus Testing

By Lou Whiteman – Aug 18, 2020 at 5:11PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The airline is working to restore consumer confidence in flying.

Delta Air Lines (DAL 0.93%) said Tuesday it is working with CVS Health (CVS 0.92%) to speed employee COVID-19 testing, the latest step by an airline to try to build consumer confidence and get travelers flying again.

Delta said that CVS clinicians working in airline crew lounges will administer rapid-response nasal-swap tests in hopes of detecting COVID-19 cases among its employees. The test is designed to take less than 15 minutes to detect the virus.

A Delta plane coming in for a landing.

Image source: Delta Air Lines.

Airlines including Delta have been hit hard by the COVID-19 pandemic, with Delta second-quarter revenue falling 88% year over year. The airlines do not expect a full recovery until 2022 at the earliest, and with consumers expressing safety concerns, it is unlikely we will see any sort of a substantial recovery until there is a COVID-19 vaccine.

The move to partner with CVS is part of Delta's plan to try to increase employee and customer confidence that flying is safe. Delta earlier this year announced partnerships with the Mayo Clinic and Quest Diagnostics to test employees for active virus and antibodies, but said this extra layer of testing should give a better idea of how effective the testing is and hopefully make it safer to fly.

"We intend to use what we learn from this round of testing to make sure our retesting program is one that continues to instill confidence among our people and with consumers about traveling with Delta," Joanne Smith, an executive vice president at the airline, said in a statement.

Delta has tried repeatedly to highlight its safety efforts as a way to differentiate itself. The airline in late July announced it would block middle seats at least through the end of September and require passengers to wear masks through at least Dec. 31, just weeks after some of its major U.S. rivals came under fire from lawmakers for lifting capacity restrictions.

Earlier this spring, Delta redeployed an internal manufacturing unit to make face shields for hospital workers battling the pandemic.

Lou Whiteman owns shares of Delta Air Lines. The Motley Fool recommends CVS Health and Delta Air Lines. The Motley Fool has a disclosure policy.

Stocks Mentioned

Cvs Health Stock Quote
Cvs Health
$102.58 (0.92%) $0.93
Delta Air Lines Stock Quote
Delta Air Lines
$35.71 (0.93%) $0.33
Quest Diagnostics Stock Quote
Quest Diagnostics
$150.46 (-1.41%) $-2.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.